glp-1 obesity drug news october 9 2025 Alarming rise in weight loss overdoses Popular GLP-1 medications may have

analyzed data from the FDA database and found that patients treated with exenatide had a 6-fold higher incidence of pancreatitis compared to those treated with other diabetes medications, such as rosiglitazone, nateglinide, repaglinide and glipizide [164]

Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells

This is why LED therapy works so well as part of an ongoing skin or wellness routine rather than a one-time treatment

Central Nervous System Effects : These medications interact with GLP-1 receptors in the hypothalamus and other brain regions that regulate appetite and energy homeostasis

We were just absolutely bowled over by the magnitude of the A1C lowering (measured blood glucose levels) and the weight loss. GLP-1 stands for glucagon-like peptide-1, a hormone the body produces naturally

Effect of 3 years of treatment with exenatide on postprandial glucagon levels